Saturday, January 25, 2025

Novo: Amycretin Causes 22 Percent Weight Loss (Connecting the Dots: Barack Obama, Michelle Obama, Sidley Austin LLP, Novo Nordisk Inc., Big Pharma, Covington & Burling LLP & Soros Funding, All Networking)

Novo: Amycretin Causes 22 Percent Weight Loss (Connecting the Dots: Barack Obama, Michelle Obama, Sidley Austin LLP, Novo Nordisk Inc., Big Pharma, Covington & Burling LLP & Soros Funding, All Networking)

Newsmax.com

Friday, 24 January 2025 07:37 AM EST

(Dreamstime)

https://www.newsmax.com/health/health-news/novo-nordisk-amycretin-obesity/2025/01/24/id/1196340/

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying people with obesity or overweight treated with the drug achieved a 22% weight loss after 36 weeks.

Shares jumped on the release and traded up 7% at 1040 GMT.

Amycretin targets the same gut hormone that Wegovy mimics, known as GLP-1, but also a pancreas hormone called amylin that affects hunger.

"The results seen in the trial support the weight lowering potential of this novel unimolecular GLP-1 and amylin receptor agonist, amycretin, that we have previously seen with the oral formulation," Novo Nordisk's head of development Martin Lange said in a statement.

Novo is also developing amycretin as a weight-loss pill, which helped obese participants lose 13.1% of their weight after 12 weeks of treatment in an early-stage study.

The company said in September it plans to decide on further studies for amycretin after data from the trial with the subcutaneous version. 

Connecting the Dots:

Sidley Austin LLP was the lobby firm for Novo Nordisk Inc. and is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma).

Michelle Obama was a lawyer at Sidley Austin LLP.

Barack Obama was an intern at Sidley Austin LLP.

Faith Elizabeth Gay was an attorney at Sidley Austin LLP and is a board of adviser’s member for the American Constitution Society.

Open Society Foundations was a funder for the American Constitution Society.

George Soros is the founder & chairman for the Open Society Foundations

Robert Raben was a director at the American Constitution Society, and an assistant attorney general for the U.S. Department of Justice.

David B. Barlow was the U.S. attorney for the District of Utah for the U.S. Department of Justice and is a partner at Sidley Austin LLP.

Eric H. Holder Jr. was a board member for the American Constitution Society, the attorney general at the U.S. Department of Justice for the Barack Obama administration and is a partner at Covington & Burling LLP.

Covington & Burling LLP is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma) and was the lobby firm for Novo Nordisk Inc.

Lars Rebien Sorensen is the president & CEO for Novo Nordisk Inc. and was a supervisory board member for Bertelsmann AG.

Markus Dohle is an executive board member for Bertelsmann AG and was a director at the Atlantic Council of the United States (think tank).

Open Society Foundations was a funder for the Atlantic Council of the United States (think tank).

George Soros is the founder & chairman for the Open Society Foundations

Resources: Past Research

This new weight-loss drug is one you want to stay far away from (Past Research on Novo Nordisk)

Friday, January 1, 2016

https://thesteadydrip.blogspot.com/2016/01/this-new-weight-loss-drug-is-one-you.html

No comments: